It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The human papilloma virus (HPV) vaccine prevents infection with certain species of human papillomavirus associated with the development of cervical cancer, genital warts, and some less common cancers. Two HPV vaccines are currently on the market: Gardasil and Cervarix.
Both vaccines protect against the two HPV types (HPV-16 and HPV-18) that cause 70% of cervical cancers, 80% of anal cancers, 60% of vaginal cancers, and 40% of vulvar cancers. These HPV types also cause most HPV induced oral cancers, and some other rare genital cancers. Gardasil also protects against the two HPV types (HPV-6 and HPV-11) that cause 90% of genital warts.
The World Health Organization (WHO), as well as public health officials in Australia, Canada, Europe, and the United States recommend vaccination of young women against HPV to prevent cervical cancer, and to reduce the number of treatments for cervical cancer precursors.
NHS Choices has carried out an assessment of press reports that “experts are calling for boys to be vaccinated against the human papilloma virus (HPV) after a study found that 50% of men are infected with the virus.”
Previous research has looked at the possibility of an HPV vaccination programme for boys in this country and found that it would not be cost-effective. It concludes that the data are useful and informative, but it is an oversimplification to claim that boys should be vaccinated on the basis of these findings. It stressed that most cancers caused by HPV occur in females, who therefore stand to benefit more from vaccination on an individual level.
Male vaccination is possible in the UK although it is done privately and, at the time of writing, outside the terms of the vaccine's licence
Probably not. There is a debate about whether it might be worth the NHS routinely vaccinating boys but while this might help to protect girls, it’s probably not going to be cost-effective for men since penile and anal cancers are very rare and genital warts while unpleasant are not fatal. Individual men will make their own choice.
The safety of HPV vaccines was studied in clinical trials worldwide before licensure. For Gardasil® , over 29,000 males and females participated in these trials. For Cervarix®, over 30,000 females participated in several clinical trials.
As of September 15, 2011, there have been a total 71 VAERS reports of death among those who have received Gardasil®. There were 57 reports among females, 3 were among males, and 11 were reports of unknown gender. Thirty four of the total death reports have been confirmed and 37 remain unconfirmed
Originally posted by Sinny
reply to post by bacci0909
I didn't realise there were to sides to the discussion? Whats the other side?
Also, has this thread appeared on new topics? Mine have not refreshed for a good hour or soedit on 1-5-2012 by Sinny because: (no reason given)
Originally posted by Sinny
I understand that there are alot of genuine conspiracies in the maedical market....but how to we distinguish these from actual medical break throughs?